Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis
Authors:
- Tobias BäuerleTBTobias Bäuerle
- Sönke BartlingSBSönke Bartling
- Martin BergerMBMartin Berger
- Annette Schmitt-GräffASAnnette Schmitt-Gräff
- Heidegard HilbigHHHeidegard Hilbig
- Hans-Ulrich KauczorHKHans-Ulrich Kauczor
- Stefan DelormeStefan Delorme
- Fabian KiesslingFKFabian Kiessling
- 1 February 2010
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 73 (2) , 280-287
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Bevacizumab Inhibits Breast Cancer-Induced Osteolysis, Surrounding Soft Tissue Metastasis, and Angiogenesis in Rats as Visualized by VCT and MRINeoplasia, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple MyelomaClinical Cancer Research, 2007
- Bone Imaging in Metastatic Breast CancerJournal of Clinical Oncology, 2004
- Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imagingInternational Journal of Cancer, 2001
- Funktioelle Magnetresonanztomographie in Diagnostik und Therapiemonitoring beim Multiplen MyelomDer Radiologe, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Skeletal complications of malignancyCancer, 1997
- Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR ImagingJournal of Computer Assisted Tomography, 1991
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977